Delphia Therapeutics is a Biotech company. It has raised $67M in total funding. Latest round: Series A. Backed by GV, Nextech Invest, Polaris Innovation Fund.
Delphia Therapeutics is a Biotech company. Delphia Therapeutics has raised $67M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2024. The round record for Delphia Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include GV, Nextech Invest, Polaris Innovation Fund, Alexandria Venture Investments. 4 distinct backers are named across the disclosed rounds.
Every Delphia Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026